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Abstract
Background: Somatic cell nuclear transfer (scNT)-derived piglets have high rates of mortality, including stillbirth and
postnatal death. Here, we examined severe malformed umbilical cords (MUC), as well as other organs, from nine scNT-
derived term piglets.
Results: Microscopic analysis revealed complete occlusive thrombi and the absence of columnar epithelial layers in MUC
(scNT-MUC) derived from scNT piglets. scNT-MUC had significantly lower expression levels of platelet endothelial cell
adhesion molecule-1 (PECAM-1) and angiogenesis-related genes than umbilical cords of normal scNT piglets (scNT-N)
that survived into adulthood. Endothelial cells derived from scNT-MUC migrated and formed tubules more slowly than
endothelial cells from control umbilical cords or scNT-N. Proteomic analysis of scNT-MUC revealed significant down-
regulation of proteins involved in the prevention of oxidative stress and the regulation of glycolysis and cell motility, while
molecules involved in apoptosis were significantly up-regulated. Histomorphometric analysis revealed severe calcification
in the kidneys and placenta, peliosis in the liver sinusoidal space, abnormal stromal cell proliferation in the lungs, and
tubular degeneration in the kidneys in scNT piglets with MUC. Increased levels of apoptosis were also detected in organs
derived from all scNT piglets with MUC.
Conclusion: These results suggest that MUC contribute to fetal malformations, preterm birth and low birth weight due
to underlying molecular defects that result in hypoplastic umbilical arteries and/or placental insufficiency. The results of
the current study demonstrate the effects of MUC on fetal growth and organ development in scNT-derived pigs, and
provide important insight into the molecular mechanisms underlying angiogenesis during umbilical cord development.
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Background
In the past decade, several species of animal, including
goat, pig, sheep and cattle, have been cloned using scNT
techniques [1]. However, while cloning is widely used in
basic research, as well as in some biomedical and agricul-
tural applications, a number of substantial problems exist
with the current technologies, including relatively low
success rates and severe defects of the fetus and/or pla-
centa resulting in abortion, neonatal death and postnatal
disease [2-4]. It has been suggested that a major cause of
early fetal loss of cloned animals is the high incidence of
placental abnormalities that can occur throughout the
entire gestation period.
Studies have shown that aberrant methylation in the tro-
phetoderm of cloned blastocysts can induce global gene
dysregulation in extra-embryonic regions, and that this
type of gene dysregulation can potentially lead to the
development of a dysfunctional placenta and have a det-
rimental effect on overall fetal development [5-7]. It has
long been recognized that the major limitation of animal
cloning with regard to efficient animal production relates
to inadequate conceptus--maternal interactions through
the placenta [8]. This inadequacy leads to deficiencies in
fetal growth in utero, which can affect the survival, health
and well-being of the newborn and the productivity of the
animal at adulthood. Inadequate conceptus-maternal
interaction is particularly acute in animal production
using scNT. The incidence of abnormal placental develop-
ment is very high in scNT-derived animals, and is largely
responsible for the frequent fetal loss, late-term pregnancy
complications and perinatal mortality associated with this
technique [9]. Recently, we were able to successfully clone
piglets using scNT, but the procedure resulted in high level
of phenotypic abnormalities that compromised fetal and
postnatal health [3,7,10,11]. As a result, the birth rate and
postnatal survival of the cloned piglets was very low. Sub-
sequently, we determined that the low birth rate of the
cloned animals was due largely to abnormal levels of
apoptosis in extraembryonic tissue during early preg-
nancy [3,12] and/or placental insufficiency at term [11].
A number of human umbilical cord malformations have
been documented, most of which involve blood vessels
[13]. One such arterial malformation, human single
umbilical artery (SUA) syndrome, in which one of the two
umbilical arteries is absent in the cord, is believed to be
caused by insufficient irrigation of the terminal portion of
the embryo. SUA syndrome affects 0.2-1% of pregnancies,
and the clinical symptoms vary depending on the stage of
development at which it occurs [14]. Hypoplasia of one of
the two umbilical arteries also occurs, albeit much less fre-
quently (0.03% of pregnancies). Hypoplastic umbilical
arteries (HUAs) are defined as malformed arteries that
exhibit an artery-artery diameter difference of approxi-
mately 50%. HUAs are associated with pre/perinatal mor-
bidity and congenital abnormalities, and have also been
linked to intrauterine growth retardation, maternal diabe-
tes, polyhydramnios and congenital cardiopathy [15]. The
development of HUAs most likely represents an incom-
plete form of SUA syndrome [16].
Of the 65 term piglets generated by scNT, we observed the
high incidence of umbilical cord malformation (9/65,
13.9%), which led us to speculate that piglets with MUC
might be a good model for studying human HUA syn-
drome. In the current study, we demonstrated that scNT
piglets with MUC exhibit impaired endothelial cell migra-
tion and angiogenesis, defects that might underlie the
development of HUA and/or placental insufficiency in
these animals. We also analyzed gene and protein expres-
sion patterns in the umbilical cord to identify putative
umbilical cord markers (either proteins or protein modi-
fications) that were associated with poor outcomes for the
fetus. Using this approach, we can begin to elucidate the
effects of MUC on fetal growth and organ development in
scNT-derived pigs, and to investigate the molecular mech-
anisms of angiogenesis during umbilical cord develop-
ment.
Methods
Animals were maintained and experiments were con-
ducted in accordance with the Kon-Kuk University Guide
for the Care and Use of Laboratory Animals.
Somatic cell nuclear transfer and embryo transfer
Nuclear transfer was carried out as described in previous
reports [10,11,17]. Briefly, the matured eggs with the first
polar body were cultured in medium supplemented with
0.4 mg/ml demecolcine (Sigma) and 0.05 mol/l sucrose
for 1 hour (hr). Sucrose was used to enlarge the perivitel-
line space of the eggs. Treated eggs with a protruding
membrane were moved to medium supplemented with 5
mg/ml cytochalasin B and 0.4 mg/ml demecolcine and
the protrusion was removed with a beveled pipette. A sin-
gle donor fetal fibroblast cell derived from gestational day
30-derived Duroc, Berkshire and 3 way hybrid (Landrace
× Duroc × Yorkshire) fetus was injected into the perivitel-
line space of each egg and electrically fused using two
direct current pulses of 150 V/mm for 50 msec in 0.28
mol/L mannitol supplemented with 0.1 mM MgSO4 and
0.01% polyvinyl alcohol (Sigma). Fused eggs were cul-
tured in medium with 0.4 mg/ml colcemid for 1 h before
parthenogenetic activation, and then cultured in 5 mg/ml
of CB-supplemented medium for 4 h. The reconstructed
oocytes were activated by 2 direct current pulses of 100 V/
mm for 20 msec in 0.28 mol/L mannitol supplemented
with 0.1 mmol/L MgSO4, and 0.05 mmol/L CaCl2. Acti-
vated eggs were cultured in the medium for 6 days in an
atmosphere of 5% CO2 and 95% air at 39°C.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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Gilts (Duroc × Yorkshire × Landrace) of at least eight
months of age were used as recipients. Estrus synchroniza-
tion of recipients was carried out as reported previously
[10,11]. ScNT embryos were surgically transferred into
oviducts of synchronized recipients. The pregnancy status
of recipients was determined by ultrasound between days
30-35. Recipients produced scNT-derived piglets via vagi-
nal delivery.
Umbilical cord samples obtained from three control pig-
lets and 65 scNT-derived piglets were washed with PBS
and used for the purification of endothelial cells or analy-
sis of gene and protein expression. scNT-N samples with
normal phenotype after 6 month of birth were selected by
comparing with control groups and used for further exper-
iments.
Isolation and characterization of porcine umbilical vein-
derived endothelial cells (PUVEC)
PUVEC were obtained from MUC (designated as scNT-
MUC) and normal (designated as scNT-N) umbilical
cords from scNT piglets, or normal umbilical cords from
piglets derived by artificial insemination (designed as
control), as described previously [18]. PUVEC were grown
until they reached confluence (between 3 to 5 days), and
were re-fed every 2 to 3 days by exchanging half of the
growth medium with fresh medium. Alternatively,
PUVEC were stored in liquid nitrogen until use. The purity
of each PUVEC population was confirmed by immunos-
taining with an anti-PECAM-1 (CD31) antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and counter-
staining with 4',6-diamidino-2-phenylindole (DAPI;
1:15,000, Sigma, St. Louis, MO).
RNA isolation and real time reverse transcriptase (RT)-
PCR
Total RNA was extracted from umbilical cord tissue using
a Micro-to-Midi Total RNA Purification System (Life Tech-
nologies Inc., Carlsbad, CA, USA). Real-time RT-PCR was
conducted using a DNA Engine OPTICON2 system (MJ
Research, San Francisco, CA, USA) and SYBR Green as the
double-stranded DNA-specific fluorescent dye (SYBR
Green qPCR premix, FINNZYMES, Woburn, MA, USA).
Target gene expression levels were normalized to tubulin
gene expression, which was unaffected in scNT-derived
pigs. The RT-PCR primer sets are shown in Additional file
1. Real-time RT-PCR was independently performed in
triplicate for different samples and the data were
expressed as the mean value of gene expression measured
in individual control, scNT-N and scN-MUC, using each
individual animal as experimental unit.
Endothelial cell (EC) migration/motility assay
Migration assays were performed as described by Rudolph
et al [19], with slight modifications. PUVEC were grown in
35 mm culture dishes to 80% confluence. A wound was
formed by clearing the monolayer from an area of the dish
with a 200 μl pipette tip. The boundary of the wound was
marked and the cells were allowed to incubate for 24 hr.
The cells were fixed, stained with a 1:10 dilution of
Giemsa (Sigma), and then photographed. Cell migration
was measured by counting the number of cells that
migrated into the cleared area of the dish. Data represents
the means of four different random fields.
Tubule formation assay
Matrigel-sandwich tubule formation assays were per-
formed as described previously [16,20]. Briefly, cold
Matrigel solution was added to a 96-well plate and
allowed to air-dry. Following rehydration of the Matrigel,
ECs derived from control, scNT-N or scNT-MUC were
seeded onto the Matrigel at a density of 10,000 cells per
well, and then allowed to incubate at 37°C for 24 hr.
Microtubules were visualized by microscopy and photo-
graphed using a digital camera.
2-dimensional gel electrophoresis (2-DE)
2-DE analysis was performed by using 3 controls, 3 scNT-
N, and 6 scNT-MUC samples with three replicates inde-
pendently. Umbilical cords were solubilized in lysis buffer
containing 7 M urea, 2 M thiourea, 4% w/v CHAPS, 40
mM DTT and 0.5% Pharmalyte pH 4-7. Insoluble material
was removed by centrifugation. IPG strips (17 cm, pH 4-
7, Bio-Rad, Hercules, CA, USA) were rehydrated overnight
in 300 μL of lysate containing 500 μg of protein. Isoelec-
tric focusing was performed using a Protein IEF Cell (Bio-
Rad). The focused strips were then equilibrated by incu-
bating them first in equilibration solution (6 M urea, 30%
v/v glycerol, 2% w/v SDS, 50 mM Tris-Hcl, pH 8.8) con-
taining 1% w/v DTT for 15 min, followed by a second
incubation in 2.5% w/v iodoacetamide in the same equi-
libration solution for 15 min. 2-DE was performed using
0.7 cm thick, 18 × 18 cm linear gradient gels (7.5-17.5%)
in a Protein ∏ xi 2-D Cell apparatus (Bio-Rad). The gels
were stained with silver or Coomassie Brilliant Blue G250
to visualize proteins. Images of stained gels were digitized
with a densitometer (Versa Doc Imagin System 1000™,
Bio-rad). The density of spots was detected and counted
by both automation and manual spot-detection, and sta-
tistically analyzed with PDQuest software (Version 7.1.1,
Bio-Rad). Protein expression data from gels were normal-
ized for the total density presented in gel images. Protein
identification procedure was described in detail in Addi-
tional file 2.
Western blot analysis
Western blot analysis was performed as described previ-
ously [3,11]. Molecular weight standards were obtained
from New England Biolabs (Ipswich, MA, USA). Mem-
branes were probed with primary antibodies recognizingBMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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the following proteins: SOD-Cu/Zn, SOD-Mn, and aldose
reductase were gifts from Dr. Seo H-G (Gyeongsang
National University, Jinju, South Korea). peroxiredoxin-2,
-4, Bax and Annexin-A5, HSP-27 antibodies were pur-
chased from Santa Cruz (CA, USA). Active- and pro-cas-
pase-3, active- and pro-caspase-8, active PARP was from
MERK (Darmstadt, Germany). Bcl-2 and actin antibody
were from Abcam (Cambridge, UK) and CHEMICON
(Temecula, CA, USA), respectively. Thereafter, the mem-
branes were incubated with an appropriate horseradish
peroxidase-conjugated secondary antibody (Jackson
Immunoresearch, West Grove, PA, USA) and subjected to
enhanced chemiluminescence analysis (Amersham, Pis-
cataway, NJ, USA). An anti-actin antibody (1:500,
CHEMICON International) was used to verify equal pro-
tein loading. Signals were visualized by using the ECL kit
(Amersham). Band intensities of each protein expression
were quantified by Image processing and analysis using
Image J 1.23 (NIH image).
TdT-mediated dUTP-X Nicked End labeling (TUNEL) 
assay
TUNEL assays were performed as described previously
[21]. Briefly, tissue sections were incubated with TUNEL
mix (0.3 U/μL calf thymus terminal deoxynucleotidyl
transferase, 7 pmol/μL biotin dUTP, 1 mM cobalt chloride
in 1 × reaction buffer in distilled water) and then washed.
Sections were saturated and then treated with a 1:20 dilu-
tion of ExtraAvidin peroxidase antibody. After washing,
sections were incubated in DAB staining solution [1.24
mg DAB, 25 μL 3% NiCl2, 152 μL 1 M Tris-HCl (pH 7.5)
in 2 ml distilled water]. Slides were mounted in crystal
mount (Biomeda, Foster City, CA, USA) and visualized by
microscopy.
Statistics
All experimental data represent the means ± standard
deviation (SD). Analysis of angiogenesis-related gene
expression pattern in figure two were performed three
times by using 10 scNT-N and 6 scNT-MUC piglets and
the statistical significance was confirmed by using t-test.
Wound healing and tubule formation in figures five and
six were analyzed by using 2 controls, 3 scNT-N and 6
scNT-MUC samples with three replicates and the statisti-
cal significance was calculated by ANOVA and confirmed
by Duncan's multiple range procedure. Protein and
mRNA expression levels (figure seven) were examined in
3 controls, 6 scNT-MUC with three replicates and the sta-
tistical significance was confirmed by t-test.
Results and discussion
High incidence MUC in scNT-derived piglet clones
In this study, we carried out scNT using each donor
fibroblast cell derived from Duroc, Berkshire and 3 way
hybrids (Landrace × Duroc × Yorkshire). scNT embryos
were transferred and successfully produced 65 cloned pig-
lets from 24 surrogates (Table 1). The number of off-
springs was variable depending on the surrogates ranging
from 1 to 6 piglets. Genetic identification for scNT clones
was confirmed by using porcine DNA microsatellite mark-
ers (SWR1120, SW1311, and SW1327) (data not shown).
Of these 9 piglets were derived from Duroc, 12 piglets
from 3 way hybrid, and 44 piglets from Berkshire: among
them, 14 piglets (21.5%) were stillborn, 38 scNT piglets
(58.5%) died suddenly within the first week of life, and 3
piglets (4.6%) died during puberty. To date, only 10 scNT
pigs (4 piglets were derived from Duroc, 3 piglets from 3
way hybrid, and 3 clones from Birkshire) are still alive and
healthy. Analysis of 65 term scNT-derived piglet clones
revealed that nine had severe MUC, a prevalence of
13.9%. Of the 56 scNT piglets with normal umbilical
cords, twelve (21.4%) were stillborn, 33 (58.9%) died
suddenly within the first week of life, and one (1.8%) died
during puberty. Ten (17.9%) of the 56 scNT-N pigs sur-
vived into adulthood, and remain alive and healthy. Of
the nine scNT piglets with MUC, two (22.2%) were still-
born and four died within the first week of life. Of the
remaining scNT-MUC piglets, two reached puberty but
then died between 8-12 months of age. Only one of the
nine scNT-MUC piglet clones survived to adulthood. The
birth weight (0.882 ± 0.243 kg; n = 9) and placenta weight
(0.24 ± 0.04 kg; n = 9) of scNT-MUC clones were signifi-
cantly lower (p < 0.05) than those of scNT-N clones
(1.390 ± 0.675 kg and 0.28 ± 0.05 kg, respectively; n = 10)
and control piglets [1.352 ± 0.112 kg (n = 20) and 0.33 ±
0.08 kg (n = 35), respectively]. Further analyses were car-
Table 1: Efficacy of scNT-derived piglet production
Group Embryo transferred Recipients Pregnancy
(%)











65 (0.1245%) 118.4 ± 2.408
Artificial
insemination
- 12 12 0 12 (100) 144 114.5 ± 0.7
* Abortion (%) presents the percentage of aborted recipients (33) out of pregnant ones (57) at gestational day 30.
** Production efficiency of scNT-derived piglet per transferred embryo.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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ried out by using Berkshire-derived scNT clones and con-
trols to minimize breeder variability.
Upon histological examination, scNT-MUC exhibited
severe tissue damage as compared to control and scNT-N,
including tissue swelling (Figure 1A, arrows). Microscopic
analysis revealed complete occlusive thrombi in the veins
and arteries of scNT-MUC, but not in control and scNT-N
(Figure 1B). scNT-MUC also exhibited areas of irregular
outer circular smooth muscle (OCSM) and unclear
boundaries in the inner longitudinal smooth muscle
(ILSM) (Figure 1C). Analysis of umbilical cords using the
TUNEL assay to detect apoptotic nuclei clearly showed
that there was a high level of apoptosis in the ILSM of
scNT-MUC, whereas apoptotic cells were rarely detected
in the ILSM of scNT-N umbilical cords (Figure 1C; bottom
panel). These results suggested that there is severe vessel
damage to both veins and arteries in scNT-MUC.
When we examined the expression of PECAM-1 (CD31),
which is abundantly expressed in ECs [22], scNT-MUC
expressed significantly lower levels of PECAM-1 than con-
Morphological and histological analysis of control, scNT-N and scNT-MUC term piglets Figure 1
Morphological and histological analysis of control, scNT-N and scNT-MUC term piglets. A) scNT-MUC exhibited 
more swelling and severe damage as compared to control and scNT-N. Of particular interest, the tissues of scNT-MUC were 
extremely fragile as compared to control and scNT-N. B) Hematoxylin and eosin staining of umbilical vein and artery sections 
from control, scNT-N and scNT-MUC. The veins and arteries of scNT-N exhibited normal development, whereas in scNT-
MUC, they were relatively less mature. C) Regions of ILSM and OCSM in scNT-MUC exhibited severe damage. The OCSM 
was irregular and/or intermittently dense, and the ILSM had unclear boundaries as compared to scNT-N. The ILSM and epithe-
lium (E) of scNT-MUC (right bottom panel) also had more apoptotic cells than scNT-N (left bottom panel). Representative 
TUNEL assays are shown. D) Western blot analysis of control, scNT-N, and scNT-MUC using anti-PECAM-1 antibodies. β-
actin was analyzed as a control.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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trol and scNT-N (Figure 1D). PECAM-1 is an efficient sig-
naling molecule that functions in diverse aspects of
vascular biology, including angiogenesis, platelet func-
tion and the regulation of leukocyte migration [23]. Thus,
impaired expression of PECAM-1 in the umbilical cord
could be a contributing factor in the development of
umbilical cord malformation.
EC activation is initiated by the binding of proangiogenic
factors, such as vascular endothelial growth factor (VEGF),
to their cognate receptors on endothelial cells, an event
that induces the activation of angiogenic signaling path-
ways [24]. VEGF is one of the most potent inducers of vas-
cular permeability, and specifically targets ECs through
binding to specific endothelial cell surface receptors,
including VEGFR-1 and VEGFR-2. The activation of
VEGFR-1 induces endothelial permeability [25], while
VEGFR-2, which is expressed exclusively in ECs, appears
to play a pivotal role in EC differentiation and vasculogen-
esis [26]. Angiopoietin-1 (Ang-1), a key molecule in the
regulation of embryonic vascular development, binds to
and activates the endothelial specific receptor Tie2, while
Ang-2 is required for subsequent postnatal vascular
remodeling [27]. scNT-MUC had significantly lower
mRNA expression levels of VEGF, Ang-1, Ang-2, VEGFR-1
and Tie-2 (Figure 2), as compared to scNT-N umbilical
cords. The expression of VEGFR-2 was also lower in scNT-
MUC than scNT-N umbilical cords. These results sug-
gested that ECs in scNT-MUC fail to elicit mitogenic
responses and/or form tubules due to the down-regula-
tion of vascular signaling molecules (i.e. VEGF, angiopoi-
etin and/or their cognate receptors) that play essential
roles in vascular development. These defects in EC signal-
ing might be responsible, at least in part, for the develop-
mental abnormalities in scNT-MUC.
We also observed several abnormalities in scNT-MUC-
derived placentas, including villous hypovascularity and
cytotrophoblast and syncytotrophoblast hypoplasia (Fig-
ure 3). Placentas derived from scNT-N exhibited similar
abnormalities (Figure 3, middle column), however, there
were some subtle differences between scNT-MUC- and
Angiogenesis-related gene expression in scNT-N and scNT-MUC Figure 2
Angiogenesis-related gene expression in scNT-N and scNT-MUC. Real-time RT-PCR was carried out using primers 
that were specific for VEGF, Ang-1 and Ang-2, and their cognate receptors VEGFR-1, VEGFR-2 and Tie-2, respectively. Real-
time RT-PCR was independently performed in triplicate for different samples and the data were expressed as the mean value 
of gene expression measured in individual scNT-N and scN-MUC. Gene expression levels were normalized to tubulin gene 
expression, and are expressed relative to scNT, which was set as 100 (%). * p < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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scNT-N-derived placentas (Figure 3, right column). Most
scNT-MUC-derived placentas had fewer blood vessels
than normal placentas (data not shown), and exhibited
severe aponecrosis of the cytotrophoblast and syncytotro-
phoblast cells in the developing villi (Figure 3, lower right
column). In placentas in which these cells were intact,
there was a significant decrease in the expression of the
cytotrophoblast biomarker MCM-7 (Figure 3, bottom sec-
tion). These observations suggested that the placenta
abnormalities in the scNT-MUC clones may be associated
with a functional abnormality of the ECs and that this
may affect the size and survival of the developing fetus.
Umbilical-derived vein endothelial cells of scNT-MUC 
clones exhibit abnormal tubular junctions and tubule 
formation
PUVECs were obtained from the veins of control, scNT-N
and scNT-MUC, as described previously [18]. We estab-
lished five cell lines from nine scNT-MUC piglets, and
determined the purity of each PUVEC line by immunos-
taining using anti-PECAM-1 (CD31) or anti-Factor Vlll
(VWF) antibodies (data not shown). As shown in Figure
4, most of the cells derived from control, scNT-N and
scNT-MUC piglets were positive for CD31, which indi-
cated that they are umbilical-derived EC lines of relatively
high purity.
Photomicrographs of cross-sections of control, scNT-N- and scNT-MUC-derived term placentas Figure 3
Photomicrographs of cross-sections of control, scNT-N- and scNT-MUC-derived term placentas. Dewaxed par-
affin sections were stained with hematoxylin and eosin. The villi and column trophoblast cells developed normally in control 
term placentas, but were poorly developed in scNT-N and scNT-MUC placentas. Immunohistochemical analysis of MCM-7 
expression (lower panels). In control and scNT-N-derived term placentas, there was extensive MCM-7-positive immunoreactiv-
ity in cytotrophoblast (CT) and syncytiotrophoblast (ST) cells, which are located along the basement membrane layer of the 
branched villi, as well as fetal cells (fe). In contrast, MCM-7 was rarely detected in the anchoring villi of scNT-MUC-derived pla-
centas. MCM-7-positive cells in scNT-MUC-derived placentas exhibited severe damage (A: aponecrosis, arrow).BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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To determine whether the changes in angiogenesis-related
gene expression that we observed earlier in scNT-MUC
affected EC motility, we performed a migration assay
using PUVEC cell lines from control, scNT-N and scNT-
MUC piglets. PUVECs were grown to confluence and an
area of the dish (the so-called wound) was scraped clear of
cells by applying suction with a narrow tip (Figure 5-a, -c,
and --5e). Cells were allowed to incubate for 24 hr, and
then examined by microscopy. The migration of scNT-
MUC-derived PUVECs was significantly impaired as com-
pared to control and scNT-N-derived PUVECs (Figure 5-b,
-d, and 5-f), with statistically significant differences in the
numbers of migrating and proliferating cells (Figure 5).
In addition to the migration and proliferation of ECs,
proper vascularization requires vascular maturation, dur-
ing which the rate of vascular sprouting is attenuated to
prevent vascular collapse. Vascular maturation involves
the recruitment of both perivascular and smooth muscle
cells [28]. We next examined the ability of scNT-MUC-
derived PUVECs to form EC junctions and tubules. Cells
were plated on Matrigel, and allowed to incubate for 6 hr.
Control and scNT-N PUVECs formed networks consisting
of cellular aggregates (nodes), with branches of elongated
strands of cells (Figure 6-a and 6-b). scNT-MUC-derived
PUVECs also formed EC junctions, but the networks con-
sisted of a small population of nodal cells, and tubular
branches with an abnormal morphology (Figure 6-c).
scNT-MUC-derived PUVECs also formed significantly
shorter tubules than control and scNT-N PUVECs (Figure
6). These results suggested that decreased expression of
angiogenesis-related genes in scNT-MUC results in defec-
tive PUVEC migration and tubule formation.
scNT umbilical cords express low levels of glycolytic- and 
cell motility-associated proteins
The umbilical cords of rodents and large mammals,
including humans, are glucose-dependent tissues that
undergo limited mitochondrial respiration, and rely pre-
dominantly on the anaerobic conversion of glucose to lac-
tate [29]. We compared the proteomes of scNT-MUC and
control umbilical cords by 2-dimensional gel electro-
phoresis (2-DE) (see Additional file 3 and 4), and found
that the expression levels of several glycolytic enzymes
were lower in scNT-MUC (Figure 7A). For example, phos-
phoglucomutase-like protein 5, triosephosphate isomer-
ase, phosphoglycerate kinase 1 and L-lactate
dehydrogenase B chain were down-regulated by 2.4-, 7.5-
, 1.3-, and 1.4-fold, respectively. By comparison, a
number of enzymes involved in aerobic metabolism (TCA
cycle) were up-regulated in scNT-MUC (Figure 7A and see
Additional file 4). These results suggested that, unlike nor-
mal umbilical cords, scNT-MUC lack sufficient protection
from oxidative damage due to the decreased expression of
key glycolytic enzymes and antioxidant proteins. Several
other classes of protein whose expression differed
between control umbilical cords and scNT-MUC were
identified, and included proteins involved in detoxifica-
tion, chaperone activity, signal transduction and cytokine
activity (see Additional file 4). Of note, several proteins
involved in the regulation of the cytoskeleton and motil-
ity were differentially expressed in control umbilical cords
and scNT-MUC.
We performed real-time RT-PCR to validate some of the
data derived from 2-DE analysis, and to investigate the
relationship between the mRNA and protein expression
levels of cytoskeletal- and motility-related proteins. As
shown in Figure 7B, the mRNA levels of destrin, WD-
repeat protein 1 (WD-1), desmin, ubiquitous tropomod-
Immunohistochemical analysis of ECs derived from control (a), scNT-N (b), and scNT-MUC (c) Figure 4
Immunohistochemical analysis of ECs derived from control (a), scNT-N (b), and scNT-MUC (c). Cells were cul-
tured in vitro and then stained using an anti-CD31 (PECAM-1, red) antibody, followed by counterstaining of nuclear DNA with 
DAPI (blue). Insets show individual cells.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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ulin 3 (TMOD3), cofilin, transgelin, tropomyosin 1 alpha
(TPM-1), calpain small subunit (CAPNS1), tropomyosin
1 beta (TPM-2), actin and tropomyosin alpha 4 chain
(TPM-4) were significantly lower in scNT-MUC (p < 0.05)
than in control. In particular, there was a pronounced dif-
ference in the mRNA expression level of destrin (Figure
7B, p < 0.01). When we directly compared protein and
mRNA expression patterns, with the exception of alpha-
centractin, all cytoskeletal and motility-related proteins
exhibited similar patterns of down-regulation at both the
protein and mRNA levels in scNT-MUC (Figure 7B). Thus,
mRNA expression levels in the umbilical cord closely mir-
rored protein expression levels. The exception was alpha-
centractin, which was up-regulated at the protein level,
and down-regulated at the mRNA level in scNT-MUC.
These results suggested that alterations in the expression
of proteins involved in the cytoskeleton and motility lead
to defects in placental EC migration and tubule forma-
tion. Defects in EC signal transduction and function could
lead to the characteristic disorganization of myofibers in
scNT-MUC-derived placentas.
Up-regulation of apoptotic proteins and down-regulation 
of oxidative repair proteins in scNT-MUC
A number of proteins involved in apoptosis and cell cycle
signaling were consistently altered in scNT-MUC relative
to control umbilical cords (see Additional file 4). In par-
ticular, proteins in two major categories of apoptosis-
related proteins, lipid-binding and oxireductase activity,
were frequently altered in scNT-MUC. The lipid-binding
apoptosis-related proteins Annexin A1, A2, and A5 were
up-regulated in scNT-MUC. Annexins are structural pro-
teins that bind to phospholipids in a Ca+2-dependent
manner, and are well-characterized apoptosis biomarkers
Wound healing assay Figure 5
Wound healing assay. scNT-MUC-derived PUVECs (e and f) had significantly lower levels of cell migration than control (a 
and b) and scNT-N (c and d) PUVECs. The graph shows the number of cells that migrated into the wound 24 hr after wound-
ing. The data were expressed as the mean value of cell numbers measured in individual control, scNT-N and scN-MUC with at 
least 3 independent experiments. * P < 0.05.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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[30]. The expression levels of lamin A and HSP27 were
also up-regulated in scNT-MUC as compared to controls.
Lamin is cleaved by members of the interleukin-convert-
ing enzyme family during apoptosis [31], and HSP27
(and HSP71) induces apoptosis through the activation of
the caspase cascade [32]. These results were indicative of
increased levels of apoptosis in scNT-MUC. The oxireduct-
ase activity-related proteins peroxiredoxin (Prx)-2 and -4
and Cu/Zn superoxide dismutase (SOD) were signifi-
cantly down-regulated in scNT-MUC, which suggested
that damaging reactive oxygen species (ROS) accumulate
in scNT-MUC and contribute to apoptosis [33].
To identify the minimal repertoire of molecules involved
in the development of MUC while also controlling for var-
iation due to scNT, we carried out a comparative pro-
teomic analysis of scNT-N and scNT-MUC using 2-DE
followed by MALDI-TOF/TOF mass spectrometry. We
identified 70 protein species that appeared to be differen-
tially expressed in scNT and scNT-MUC (see Additional
file 5 and 6). Among them, 35 were present at higher lev-
els in scNT-MUC, while 25 were present at lower levels as
compared to scNT-N. Additional file 6 summarizes the
main properties of 40 of the proteins identified that were
differentially regulated in scNT-MUC and scNT-N. The
expression of apoptosis-related proteins (annexin A2, A5,
and HSP 27) was up-regulated, whereas the expression of
cell motility and structural proteins (heat-shock 20 kDa
like-protein p20, transgelin, tubulin-specific chaperone A,
LIM and SH3 protein 1, destrin), and detoxification pro-
teins [Prx-2, -4, SOD-Cu/Zn, aldose reductase (AR)] was
down-regulated (Figure 8A and 8D). Western blot analysis
confirmed the up-regulation of annexin A5 and HSP27,
and the down-regulation of AR, SOD-Cu/Zn, SOD-Mn,
Prx-2 and Prx-4 in scNT-MUC (Figure 8B and 8D).
Given the apparent increase in the expression of apopto-
sis-related proteins in scNT-MUC, we next examined the
expression of several proteins that are key factors in pro-
grammed cell death. The level of expression of the anti-
In vitro junction and tubule formation assay Figure 6
In vitro junction and tubule formation assay. Control and scNT-N-derived PUVECs formed an extensive capillary-like 
network 24 hr after plating onto Matrigel (a and b), while scNT-MUC PUVECs formed a truncated and abnormal network (c). 
Cells were viewed by phase-contrast microscopy. Magnification, 40×. Tubule length was measured under a microscope and 
then average tubule length was plotted. The data were expressed as the mean value of tubule length measured in individual 
control, scNT-N and scN-MUC with at least 3 independent experiments. * P < 0.05, ** P < 0.01.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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apoptotic protein Bcl-2 was lower in scNT-MUC than
scNT-N, whereas Bax, active poly (ADP-ribose) polymer-
ase (PARP) and pro/active caspases 3 and 8 were signifi-
cantly up-regulated (Figure 8C and 8D). PARP is an
important substrate of caspase-3 that is cleaved from a
112-kDa fragment into an 85-kDa fragment upon cas-
pase-3 activation [31,32,34]. These results provided addi-
tional evidence of active apoptosis in scNT-MUC. While
the elimination of unwanted cells during development is
essential, inappropriate or elevated apoptosis in the
umbilical cord can result in destruction or weakening of
the tissue. The umbilical cord is essential during develop-
ment, as it provides nutritional, endocrine and immune
support to the fetus. When these functions are compro-
mised due to elevated apoptosis, low placental weights
and low birth weights can ensue.
TUNEL analysis of organs from scNT-MUC piglets
To investigate the relationship between MUC and fetal
malformation, we examined several postnatal fetal organs
by microscopy (Figure 9A). We observed severe conges-
tion in the lung and liver of scNT-MUC piglets (Figure 9A-
f and 9-g). The affected tissues had a prominent red color
due to engorgement with oxygenated blood and exhibited
severe peliosis. There was also evidence of abnormal stro-
mal cell proliferation and tubular degeneration in the
lung and liver (Figure 9A-f and 9-g, arrows). Of note, dis-
tinct areas of calcification were detected in the placenta
Proteomic analysis of control and scNT-MUC Figure 7
Proteomic analysis of control and scNT-MUC. A) 2-DE analysis of differentially expressed proteins in control and scNT-
MUC. Several glycolytic enzymes and TCA-related enzymes were down- and up-regulated, respectively, in scNT-MUC relative 
to control. B) Analysis of the mRNA and protein expression levels of cell motility-related proteins in scNT-MUC relative to 
control umbilical cords. Real-time RT-PCR and 2-DE analyses were independently performed in triplicate for different samples 
and the data were expressed as the mean value of gene and protein expression measured in individual control and scNT-MUC. 
*p < 0.01; **p < 0.001.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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and kidney (Figure 9A-e and 9-h, arrowheads). We also
measured the level of apoptosis in control and scNT-
MUC-derived placenta, lung, liver and kidney using the
TUNEL assay (Figure 9B). Whereas apoptotic cells were
barely detectable in control placentas (Figure 9B, a-d),
there was a marked elevation in apoptosis in organs
derived from scNT-MUC clones (Figure 9B, e-h). Apopto-
sis in scNT-MUC placentas was restricted primarily to
cytotrophoblast and syncytotrophoblast cells, with the
exception of a small sub-population of cells attached to
the basal membrane of the villi (Figure 9B-e and Figure 3,
lower right panel).
Recent studies from our laboratory suggest that the low
success rate of scNT cloning is due to placental abnormal-
ities rather than to cumulative genomic damage
[3,7,11,12]. The data from the current study are consistent
with this hypothesis, and indicate that small placentas
derived from scNT-MUC inflict chronic pressure on the
developing fetus, resulting in compromised organ devel-
opment. Thus, MUC contribute to placental insufficiency,
and ultimately influence fetal development, malforma-
tion and birth rates.
Conclusion
Our observations suggest that due to MUC, the blood flow
may be reduced between placenta and fetus, resulting in
an increase in apoptosis in the umbilical cord. Because the
umbilical cord plays a fundamental role in transporting
metabolites between mother and fetus, MUC also contrib-
ute to placental insufficiency by preventing the removal of
harmful materials from fetal circulation. MUC might also
promote hypoxia and the accumulation of CO2, while
diminishing O2 levels in fetal organs, stimulating apopto-
sis in the developing fetus. Thus, the functional conse-
quences of MUC in scNT-derived animals are potentially
Proteomic analysis of scNT-N and scNT-MUC by 2-DE and Western blot Figure 8
Proteomic analysis of scNT-N and scNT-MUC by 2-DE and Western blot. A) Representative up- and down-regu-
lated proteins from scNT-N and scNT-MUC are shown. B and C) Western blot analysis of ROS- and apoptosis-related pro-
teins in scNT-N and scNT-MUC. The amount of total protein loaded per lane was 15-30 μg; β-actin was analyzed as a loading 
control. D) Fold changes of differentially expressed proteins in scNT-N and scNT-MUC by 2-DE gel or Western blotting.BMC Genomics 2009, 10:511 http://www.biomedcentral.com/1471-2164/10/511
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severe, and include not only placental insufficiency, fetal
abnormalities and mortality, but also fetal malforma-
tions, preterm birth, and low birth weight. Our data sug-
gest that these effects are due to specific molecular defects
that lead to the development of HUA and/or placental
insufficiency. In summary, the results of the current study
provide several clues to a better understanding of the
molecular mechanisms of angiogenesis during umbilical
cord development, as well as a robust model for the study
of HUA syndrome in humans.
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Analysis of organs derived from control and scNT-MUC piglets. A) Microscopic analysis revealed evidence of severe 
calcification in scNT-MUC-derived placenta (e) and kidney (h). Lung (f) and liver (g) sections derived from scNT clones with 
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